Skip to content
DefDex

Federal award

ARBUTUS BIOPHARMA CORPORATION

W9113M10C0057

Contract

Obligated and Ceiling

Obligated (net)
$52,187,135.45
Ceiling (potential value, not spending)
$157,226,529.24
Current value
$122,547,197.24
Gross positive obligations
$78,821,174.24

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
ARBUTUS BIOPHARMA CORPORATION · Z6GEANC7LJP1
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
ARBUTUS BIOPHARMA CORPORATION · Z6GEANC7LJP1
Awarding agency
Department of War · sub-agency 2100 · office W911QY
Funding agency
Department of War · sub-agency 2100
Product or service (PSC)
AN13 · HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT
Industry (NAICS)
541711 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
PIID
W9113M10C0057
Award type code
D
Actions
46 · Jul 14, 2010 to Jan 22, 2018
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History46

Award actions
DateFYModAction typeObligationCompany in company totals
Jan 22, 2018FY2018P00044M$0.00
—
Dec 14, 2017FY2018P00043K−$559,672.23
—
Jan 20, 2016FY2016P00042C−$17,185,179.56
—
Nov 6, 2015FY2016P00041M$0.00
—
Oct 14, 2015FY2016P00040M$0.00
—
Oct 1, 2015FY2016P00039M$0.00
—
Sep 16, 2015FY2015P00038M$0.00
—
May 26, 2015FY2015P00037D$1,690,592.00
—
May 13, 2015FY2015P00036C$14,988,769.00
—
Apr 30, 2015FY2015P00035B$183,500.00
—
Mar 31, 2015FY2015P00034B$0.00
—
Mar 4, 2015FY2015P00033D$2,250,000.00
—
Mar 4, 2015FY2015P00032G$0.00
—
Nov 17, 2014FY2015P00031C$6,341,423.32
—
Nov 1, 2014FY2015P00030B$658,576.68
—
Oct 9, 2014FY2015A00002M$0.00
—
Sep 24, 2014FY2014P00029B$0.00
—
Sep 9, 2014FY2014P00028B$0.00
—
Jul 25, 2014FY2014P00026B$0.00
—
Jul 25, 2014FY2014P00027M$0.00
—
Apr 23, 2014FY2014P00025B$2,100,000.00
—
Jun 19, 2013FY2013P00024C$6,286,883.18
—
May 21, 2013FY2013P00023M$5,873,551.06
—
May 1, 2013FY2013P00022B$0.00
—
Mar 29, 2013FY2013P00021B$0.00
—
Feb 28, 2013FY2013P00020C$1,700,000.00
—
Jan 4, 2013FY2013P00019C$2,000,000.00
—
Dec 20, 2012FY2013P00018B$0.00
—
Oct 22, 2012FY2013P00017B$0.00
—
Oct 2, 2012FY2013P00016B$0.00
—
Oct 1, 2012FY2013P00015B$0.00
—
Sep 4, 2012FY2012P00014B$0.00
—
Aug 27, 2012FY2012P00013M$0.00
—
Aug 3, 2012FY2012P00012D$0.00
—
Jul 25, 2012FY2012P00011C−$8,889,187.00
—
Jul 16, 2012FY2012P00010M$0.00
—
Jul 6, 2012FY2012P00009C$0.00
—
Apr 23, 2012FY2012P00008C$10,569,177.00
—
Mar 5, 2012FY2012P00007C$2,920,010.00
—
Jan 25, 2012FY2012P00006D$0.00
—
Dec 2, 2011FY2012P00005C$3,950,000.00
—
Oct 5, 2011FY2012P00004B$0.00
—
Jun 20, 2011FY2011P00003C$3,000,000.00
—
Apr 15, 2011FY2011P00002C$4,553,366.00
—
Jul 19, 2010FY2010P00001M$0.00
—
Jul 14, 2010FY20100—$9,755,326.00
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.